90
Participants
Start Date
August 31, 2013
Primary Completion Date
May 21, 2019
Study Completion Date
May 21, 2019
omega-3 and -6 fatty acids and their 12-LOX oxylipins
platelets from healthy subjects and T2DM patients will be isolated from their blood and treated with omega-3 and -6 fatty acids and their 12-LOX oxylipins of those fatty acids followed by assessment of protection from agonist-induced platelet activation and thrombosis
Thomas Jefferson University, Philadelphia
University of Michigan, Ann Arbor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Michigan
OTHER